20 stocks of companies showing excellent earnings-season trends even as the economy coolsMarket Watch • 05/12/25
Eli Lilly's Zepbound outperforms Novo Nordisk's Wegovy in obesity drug trialProactive Investors • 05/12/25
Pharma Stocks Hit by Trump's Vow to Cut US Prescription Drug CostsZacks Investment Research • 05/12/25
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (May 2025)24/7 Wall Street • 05/12/25
Zepbound (tirzepatide) showed superior weight loss over Wegovy (semaglutide) in complete SURMOUNT-5 results published in The New England Journal of MedicinePRNewsWire • 05/11/25
Lilly plans to expand Purdue University collaboration with up to a $250 million investment to accelerate pharmaceutical innovationPRNewsWire • 05/09/25
One of the Largest Teacher Pension Funds in the U.S. Sold Nvidia, Tesla, and Apple and Piled Into a Popular Pharmaceutical Stock Up 395% Over the Last 5 YearsThe Motley Fool • 05/08/25
Healthy Returns: Novo Nordisk's Wegovy deal with CVS won't derail Eli Lilly's obesity market dominanceCNBC • 05/07/25
Eli Lilly Being Investigated on Behalf of Eli Lilly and Company Investors. Contact Levi & Korsinsky For DetailsAccesswire • 05/07/25
LLY ACTIVE INVESTIGATION: Contact Levi & Korsinsky if you lost money on your Eli Lilly and Company investmentAccesswire • 05/06/25